DailyMed - CETIRIZINE HCL- cetirizine tablet CETIRIZINE HCL- cetirizine kit

NDC Code(s): 72657-128-03, 72657-128-04, 72657-128-08, 72657-128-14, view more
72657-128-15, 72657-128-18, 72657-128-24, 72657-128-30, 72657-128-35, 72657-128-41, 72657-128-45, 72657-128-60, 72657-128-70, 72657-128-81, 72657-128-82, 72657-128-84, 72657-128-86, 72657-128-90, 72657-129-03, 72657-129-04, 72657-129-08, 72657-129-14, 72657-129-15, 72657-129-18, 72657-129-24, 72657-129-30, 72657-129-35, 72657-129-41, 72657-129-45, 72657-129-60, 72657-129-70, 72657-129-81, 72657-129-82, 72657-129-84, 72657-129-86, 72657-129-90, 72657-130-05, 72657-131-89
Packager: GLENMARK THERAPEUTICS INC., USA

Category: HUMAN OTC DRUG LABEL
DEA Schedule: None
Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated April 21, 2025

If you are a consumer or patient please visit this version.

Download DRUG LABEL INFO: PDF XML
Official Label (Printer Friendly)

View All Sections

ACTIVE INGREDIENT
Cetirizine HCl 5 mg - Cetirizine HCl 10 mg

Cetirizine HCl 5 mg

Cetirizine HCl 10 mg
Close
PURPOSE
Antihistamine

Antihistamine
Close
INDICATIONS & USAGE
Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: • runny nose, • sneezing, • itchy, watery eyes, • itching of the nose or throat

Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

•

runny nose,

•

sneezing,

•

itchy, watery eyes,

•

itching of the nose or throat

Close
WARNINGS
Do not use if you have ever had an allergic reaction to this product or any of its ingredients or an antihistamine containing hydroxyzine - Ask a doctor before useif you have liver or kidney ...

Do not use if you have ever had an allergic reaction to this product or any of its ingredients or an antihistamine containing hydroxyzine

Ask a doctor before useif you have liver or kidney disease.

Your doctor should determine if you need a different dose.

Ask a doctor or pharmacist before use if you are taking tranquilizers or sedatives

When using this product

•

drowsiness may occur

•

avoid alcoholic drinks

•

alcohol, sedatives, and tranquilizers may increase drowsiness

•

be careful when driving a motor vehicle or operating machinery

Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.

If pregnant or breast-feeding:

•

If breast-feeding: not recommended

•

if pregnant: ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222)

Close

DOSAGE & ADMINISTRATION

Cetirizine Hydrochloride Tablets, USP 5 mg - adults and children 6 years and over - 1 tablet (5 mg) or 2 tablets (10) once daily depending upon severity of symptoms; do not take more than 2 ...

Other information
• store between 20°C to 25°C (68°F to 77°F) • do not use of imprinted foil inner seal on bottle is broken or missing. • FDA approved organic impurities test procedure differs from USP

•

store between 20°C to 25°C (68°F to 77°F)

•

do not use of imprinted foil inner seal on bottle is broken or missing.

•

FDA approved organic impurities test procedure differs from USP

Close
INACTIVE INGREDIENT
colloidal silicon dioxide, croscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, titanium dioxide

colloidal silicon dioxide, croscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, titanium dioxide
Close
OTHER SAFETY INFORMATION
Questions or comments? call toll-free weekdays 9 AM to 5 PM EST at 1 (888) 721-7115 - Manufactured by: Glenmark Pharmaceuticals Limited - Pithampur, Madhya Pradesh 454775, India - Distributed by ...

Questions or comments?

call toll-free weekdays 9 AM to 5 PM EST at 1 (888) 721-7115

Manufactured by:

Glenmark Pharmaceuticals Limited

Pithampur, Madhya Pradesh 454775, India

Distributed by:

Glenmark Therapeutics Inc., USA

Mahwah, NJ 07430

Product of India

February 2024
Close
Package/Label Principal Display Panel
Container label - NDC 72657-129-35 - 10 mg - 365 Tablets

Container label

NDC 72657-129-35

10 mg - 365 Tablets

Close
Package/Label Principal Display Panel
NDC 72657-128-35 - 5 mg- 365 Tablets

NDC 72657-128-35

5 mg- 365 Tablets

Close
Principal Display Panel
Carton label - NDC 72657-129-35 - 10 mg - 365 Tablets

Carton label

NDC 72657-129-35

10 mg - 365 Tablets

Close
Principal Display Panel
NDC 72657-128-35 - 5 mg - 365 Tablets

NDC 72657-128-35

5 mg - 365 Tablets

Close

INGREDIENTS AND APPEARANCE

Product Information

CETIRIZINE HCL cetirizine tablet

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:72657-128
Route of Administration	ORAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
CETIRIZINE HYDROCHLORIDE (UNII: 64O047KTOA) (CETIRIZINE - UNII:YO7261ME24)	CETIRIZINE HYDROCHLORIDE	5 mg

Ingredient Name	Strength
Inactive Ingredients
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
MAGNESIUM STEARATE (UNII: 70097M6I30)
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)
POVIDONE K30 (UNII: U725QWY32X)
SODIUM STARCH GLYCOLATE TYPE A (UNII: H8AV0SQX4D)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)

Product Characteristics
Color	WHITE	Score	no score
Shape	ROUND	Size	6mm
Flavor		Imprint Code	C;13
Contains

#	Item Code	Package Description	Marketing Start Date
Packaging
1	NDC:72657-128-30	1 in 1 CARTON	05/13/2024
1		30 in 1 BOTTLE; Type 0: Not a Combination Product
2	NDC:72657-128-45	1 in 1 CARTON	05/13/2024
2		45 in 1 BOTTLE; Type 0: Not a Combination Product
3	NDC:72657-128-60	1 in 1 CARTON	05/13/2024
3		60 in 1 BOTTLE; Type 0: Not a Combination Product
4	NDC:72657-128-70	1 in 1 CARTON	05/13/2024
4		70 in 1 BOTTLE; Type 0: Not a Combination Product
5	NDC:72657-128-90	1 in 1 CARTON	05/13/2024
5		90 in 1 BOTTLE; Type 0: Not a Combination Product
6	NDC:72657-128-08	1 in 1 CARTON	05/13/2024
6		120 in 1 BOTTLE; Type 0: Not a Combination Product
7	NDC:72657-128-14	1 in 1 CARTON	05/13/2024
7		140 in 1 BOTTLE; Type 0: Not a Combination Product
8	NDC:72657-128-15	1 in 1 CARTON	05/13/2024
8		150 in 1 BOTTLE; Type 0: Not a Combination Product
9	NDC:72657-128-18	1 in 1 CARTON	05/13/2024
9		180 in 1 BOTTLE; Type 0: Not a Combination Product
10	NDC:72657-128-24	1 in 1 CARTON	05/13/2024
10		240 in 1 BOTTLE; Type 0: Not a Combination Product
11	NDC:72657-128-03	1 in 1 CARTON	05/13/2024
11		300 in 1 BOTTLE; Type 0: Not a Combination Product
12	NDC:72657-128-35	1 in 1 CARTON	05/13/2024
12		365 in 1 BOTTLE; Type 0: Not a Combination Product
13	NDC:72657-128-04	1 in 1 CARTON	05/13/2024
13		400 in 1 BOTTLE; Type 0: Not a Combination Product
14	NDC:72657-128-81	2 in 1 CARTON	05/13/2024
14		60 in 1 BOTTLE; Type 0: Not a Combination Product
15	NDC:72657-128-82	2 in 1 CARTON	05/13/2024
15		70 in 1 BOTTLE; Type 0: Not a Combination Product
16	NDC:72657-128-84	2 in 1 CARTON	05/13/2024
16		90 in 1 BOTTLE; Type 0: Not a Combination Product
17	NDC:72657-128-86	2 in 1 CARTON	05/13/2024
17		120 in 1 BOTTLE; Type 0: Not a Combination Product
18	NDC:72657-128-41	1 in 1 CARTON	05/13/2024
18		14 in 1 BOTTLE; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
ANDA	ANDA078427	05/13/2024

CETIRIZINE HCL cetirizine tablet

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:72657-129
Route of Administration	ORAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
CETIRIZINE HYDROCHLORIDE (UNII: 64O047KTOA) (CETIRIZINE - UNII:YO7261ME24)	CETIRIZINE HYDROCHLORIDE	10 mg

Ingredient Name	Strength
Inactive Ingredients
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
MAGNESIUM STEARATE (UNII: 70097M6I30)
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)
POVIDONE K30 (UNII: U725QWY32X)
SODIUM STARCH GLYCOLATE TYPE A (UNII: H8AV0SQX4D)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)

Product Characteristics
Color	WHITE	Score	no score
Shape	ROUND	Size	8mm
Flavor		Imprint Code	C;17
Contains

#	Item Code	Package Description	Marketing Start Date
Packaging
1	NDC:72657-129-30	1 in 1 CARTON	05/13/2024
1		30 in 1 BOTTLE; Type 0: Not a Combination Product
2	NDC:72657-129-45	1 in 1 CARTON	05/13/2024
2		45 in 1 BOTTLE; Type 0: Not a Combination Product
3	NDC:72657-129-60	1 in 1 CARTON	05/13/2024
3		60 in 1 BOTTLE; Type 0: Not a Combination Product
4	NDC:72657-129-70	1 in 1 CARTON	05/13/2024
4		70 in 1 BOTTLE; Type 0: Not a Combination Product
5	NDC:72657-129-90	1 in 1 CARTON	05/13/2024
5		90 in 1 BOTTLE; Type 0: Not a Combination Product
6	NDC:72657-129-08	1 in 1 CARTON	05/13/2024
6		120 in 1 BOTTLE; Type 0: Not a Combination Product
7	NDC:72657-129-14	1 in 1 CARTON	05/13/2024
7		140 in 1 BOTTLE; Type 0: Not a Combination Product
8	NDC:72657-129-15	1 in 1 CARTON	05/13/2024
8		150 in 1 BOTTLE; Type 0: Not a Combination Product
9	NDC:72657-129-18	1 in 1 CARTON	05/13/2024
9		180 in 1 BOTTLE; Type 0: Not a Combination Product
10	NDC:72657-129-24	1 in 1 CARTON	05/13/2024
10		240 in 1 BOTTLE; Type 0: Not a Combination Product
11	NDC:72657-129-03	1 in 1 CARTON	05/13/2024
11		300 in 1 BOTTLE; Type 0: Not a Combination Product
12	NDC:72657-129-35	1 in 1 CARTON	05/13/2024
12		365 in 1 BOTTLE; Type 0: Not a Combination Product
13	NDC:72657-129-04	1 in 1 CARTON	05/13/2024
13		400 in 1 BOTTLE; Type 0: Not a Combination Product
14	NDC:72657-129-81	2 in 1 CARTON	05/13/2024
14		60 in 1 BOTTLE; Type 0: Not a Combination Product
15	NDC:72657-129-82	2 in 1 CARTON	05/13/2024
15		70 in 1 BOTTLE; Type 0: Not a Combination Product
16	NDC:72657-129-84	2 in 1 CARTON	05/13/2024
16		90 in 1 BOTTLE; Type 0: Not a Combination Product
17	NDC:72657-129-86	2 in 1 CARTON	05/13/2024
17		120 in 1 BOTTLE; Type 0: Not a Combination Product
18	NDC:72657-129-41	1 in 1 CARTON	04/03/2025
18		14 in 1 BOTTLE; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
ANDA	ANDA078427	05/13/2024

CETIRIZINE HCL cetirizine kit

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:72657-130

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:72657-130-05	1 in 1 PACKAGE; Type 0: Not a Combination Product	05/13/2024

Part #	Package Quantity	Total Product Quantity
Quantity of Parts
Part 1	1 BOTTLE	60
Part 2	1 BOTTLE	90

Part 1 of 2

CETIRIZINE HCL cetirizine tablet

Product Information
Item Code (Source)	NDC:72657-128
Route of Administration	ORAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
CETIRIZINE HYDROCHLORIDE (UNII: 64O047KTOA) (CETIRIZINE - UNII:YO7261ME24)	CETIRIZINE HYDROCHLORIDE	5 mg

Ingredient Name	Strength
Inactive Ingredients
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
MAGNESIUM STEARATE (UNII: 70097M6I30)
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)
POVIDONE K30 (UNII: U725QWY32X)
SODIUM STARCH GLYCOLATE TYPE A (UNII: H8AV0SQX4D)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)

Product Characteristics
Color	WHITE	Score	no score
Shape	ROUND	Size	6mm
Flavor		Imprint Code	C;13
Contains

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1		1 in 1 CARTON
1		60 in 1 BOTTLE; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
ANDA	ANDA078427	05/13/2024

Part 2 of 2

CETIRIZINE HCL cetirizine tablet

Product Information
Item Code (Source)	NDC:72657-128
Route of Administration	ORAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
CETIRIZINE HYDROCHLORIDE (UNII: 64O047KTOA) (CETIRIZINE - UNII:YO7261ME24)	CETIRIZINE HYDROCHLORIDE	5 mg

Ingredient Name	Strength
Inactive Ingredients
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
MAGNESIUM STEARATE (UNII: 70097M6I30)
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)
POVIDONE K30 (UNII: U725QWY32X)
SODIUM STARCH GLYCOLATE TYPE A (UNII: H8AV0SQX4D)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)

Product Characteristics
Color	WHITE	Score	no score
Shape	ROUND	Size	6mm
Flavor		Imprint Code	C;13
Contains

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1		1 in 1 CARTON
1		90 in 1 BOTTLE; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
ANDA	ANDA078427	05/13/2024

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
ANDA	ANDA078427	05/13/2024

CETIRIZINE HCL cetirizine kit

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:72657-131

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:72657-131-89	1 in 1 PACKAGE; Type 0: Not a Combination Product	05/13/2024

Part #	Package Quantity	Total Product Quantity
Quantity of Parts
Part 1	1 BOTTLE	60
Part 2	1 BOTTLE	90

Part 1 of 2

CETIRIZINE HCL cetirizine tablet

Product Information
Item Code (Source)	NDC:72657-129
Route of Administration	ORAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
CETIRIZINE HYDROCHLORIDE (UNII: 64O047KTOA) (CETIRIZINE - UNII:YO7261ME24)	CETIRIZINE HYDROCHLORIDE	10 mg

Ingredient Name	Strength
Inactive Ingredients
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
MAGNESIUM STEARATE (UNII: 70097M6I30)
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)
POVIDONE K30 (UNII: U725QWY32X)
SODIUM STARCH GLYCOLATE TYPE A (UNII: H8AV0SQX4D)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)

Product Characteristics
Color	WHITE	Score	no score
Shape	ROUND	Size	8mm
Flavor		Imprint Code	C;17
Contains

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1		1 in 1 CARTON
1		60 in 1 BOTTLE; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
ANDA	ANDA078427	05/13/2024

Part 2 of 2

CETIRIZINE HCL cetirizine tablet

Product Information
Item Code (Source)	NDC:72657-129
Route of Administration	ORAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
CETIRIZINE HYDROCHLORIDE (UNII: 64O047KTOA) (CETIRIZINE - UNII:YO7261ME24)	CETIRIZINE HYDROCHLORIDE	10 mg

Ingredient Name	Strength
Inactive Ingredients
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
MAGNESIUM STEARATE (UNII: 70097M6I30)
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)
POVIDONE K30 (UNII: U725QWY32X)
SODIUM STARCH GLYCOLATE TYPE A (UNII: H8AV0SQX4D)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)

Product Characteristics
Color	WHITE	Score	no score
Shape	ROUND	Size	8mm
Flavor		Imprint Code	C;17
Contains

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1		1 in 1 CARTON
1		90 in 1 BOTTLE; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
ANDA	ANDA078427	05/13/2024

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
ANDA	ANDA078427	05/13/2024

Labeler - GLENMARK THERAPEUTICS INC., USA (969085666)

Name	Address	ID/FEI	Business Operations
Establishment
Glenmark Pharmaceuticals Limited		862603186	ANALYSIS(72657-128, 72657-129, 72657-130, 72657-131) , MANUFACTURE(72657-128, 72657-129, 72657-130, 72657-131)

View All Sections

adults and children 6 years and over	1 tablet (5 mg) or 2 tablets (10) once daily depending upon severity of symptoms; do not take more than 2 tablets (10) in 24 hours.
adults 65 years and over	1 tablet (5 mg) once a day; do not take more than 1 tablet (5 mg) in 24 hours.
children under 6 years of age	ask a doctor
consumers with liver or kidney disease	ask a doctor

Published Date (What is this?)	Version	Files
Apr 23, 2025	5 (current)	download
Dec 11, 2024	4	download
Jun 18, 2024	3	download
Jun 12, 2024	2	download

Label: CETIRIZINE HCL- cetirizine tablet
CETIRIZINE HCL- cetirizine kit

View Package Photos

VIEW MORE

Drug Label Info

Safety

Related Resources

More Info For This Drug

Drug Label Information

Keep out of reach of children.

Find additional resources

Safety

Related Resources

More Info on this Drug

adults and children 6 years and over	one 10 mg tablet once daily; do not take more than one 10 mg tablet in 24 hours. A 5 mg product may be appropriate for less severe symptoms.
adults 65 years and over	ask a doctor
children under 6 years of age	ask a doctor
consumers with liver or kidney disease	ask a doctor

	NDC
1	72657-128-03
2	72657-128-04
3	72657-128-08
4	72657-128-14
5	72657-128-15
6	72657-128-18
7	72657-128-24
8	72657-128-30
9	72657-128-35
10	72657-128-41
11	72657-128-45
12	72657-128-60
13	72657-128-70
14	72657-128-81
15	72657-128-82
16	72657-128-84
17	72657-128-86
18	72657-128-90
19	72657-129-03
20	72657-129-04
21	72657-129-08
22	72657-129-14
23	72657-129-15
24	72657-129-18
25	72657-129-24
26	72657-129-30
27	72657-129-35
28	72657-129-41
29	72657-129-45
30	72657-129-60
31	72657-129-70
32	72657-129-81
33	72657-129-82
34	72657-129-84
35	72657-129-86
36	72657-129-90
37	72657-130-05
38	72657-131-89

Label: CETIRIZINE HCL- cetirizine tabletCETIRIZINE HCL- cetirizine kit

View Package Photos

VIEW MORE

Drug Label Info

Safety

Related Resources

More Info For This Drug

Drug Label Information

Keep out of reach of children.

Find additional resources

Safety

Related Resources

More Info on this Drug

CETIRIZINE HCL- cetirizine tabletCETIRIZINE HCL- cetirizine kit

Number of versions: 4

CETIRIZINE HCL- cetirizine tabletCETIRIZINE HCL- cetirizine kit

CETIRIZINE HCL- cetirizine tabletCETIRIZINE HCL- cetirizine kit

To receive this label RSS feed

To receive all DailyMed Updates for the last seven days

What will I get with the DailyMed RSS feed?

How to discontinue the RSS feed

Why is DailyMed no longer displaying pill images on the Search Results and Drug Info pages?

CETIRIZINE HCL- cetirizine tabletCETIRIZINE HCL- cetirizine kit

If this SPL contains inactivated NDCs listed by the FDA initiated compliance action, they will be specified as such.

Label: CETIRIZINE HCL- cetirizine tablet
CETIRIZINE HCL- cetirizine kit

CETIRIZINE HCL- cetirizine tablet
CETIRIZINE HCL- cetirizine kit

CETIRIZINE HCL- cetirizine tablet
CETIRIZINE HCL- cetirizine kit

CETIRIZINE HCL- cetirizine tablet
CETIRIZINE HCL- cetirizine kit

CETIRIZINE HCL- cetirizine tablet
CETIRIZINE HCL- cetirizine kit